fda glp-1 enforcement news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA creates "green list" to

Precision Testing Assesses key amino acids and related genetics to understand metabolic needs and bottlenecks

Measuring inconsistency in meta-analyses

Both supplements should complement evidence-based treatments under medical supervision and are not recommended as substitutes for conventional therapy in cardiovascular disease or chronic fatigue syndrome

Any form of movement that you enjoy and can fit into your day is a good choice

Michelle Oravitz: So let's talk about what so we definitely, that's one of the things that um, I've been doing for egg health and also sperm [00:05:00] quality, cause it's such a high potent antioxidant